CinCor is a clinical-stage cardiorenal therapeutics company with a novel clinical-stage candidate, CIN-107 that has the potential to dramatically expand therapeutic options for patients suffering from hypertension and its associated risks.

Biotechnology

CinCor Pharma

Marc De Garidel

Mason W. Freeman

Michael Kalb

William (Bill) Marshall

Kevin Schutz, PharmD

William Marshall

Kevin Schutz

Jack Greene

James Hui

Jane Chamberland

Jonathan Isaacsohn

Scientific Team

Clinical and Medical Team

Leadership Team

Regulatory and Quality

CinCor Pharma

Org chart

Teams

Scientific Team

Clinical and Medical Team

Leadership Team

Regulatory and Quality

Similar companies